Dr. Simone Stalling, MD

Dr. Stalling practices at West Houston Plastic Surgery Center PLLC in Houston, Texas.

Dr. Stalling's NPI, 1922310911, was assigned on July 8, 2010. Dr. Stalling graduated from Perelman School of Medicine - Philadelphia in 2010. Dr. Stalling holds Texas license P9743.

Dr. Stalling's primary practice is West Houston Plastic Surgery Center PLLC, at 915 Gessner Rd, Houston, TX 77024 in Harris County. The practice phone is (713) 468-5200.

Dr. Stalling's primary practice is West Houston Plastic Surgery Center PLLC in Houston, Texas. The medical group on file is AVIVA Dermatology. Dmand AI also links Dr. Stalling to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stalling practices. Vendor and product names are available with a free account.

Dermatology is Dr. Stalling's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Stalling is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Stalling's licenses on file in 4 states: Texas, Missouri, California and Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, corns and calluses, hives and itchy rashes among the conditions Dr. Stalling treats.

CMS data shows 1,955 Medicare services from Dr. Stalling across 14 procedure codes in 2024, for 451 Medicare patients. Medicare paid $100,387 for them. Every service was in an office.

CMS counts 451 Medicare patients who saw Dr. Stalling in 2024. The largest group is 65 to 74, with 218 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stalling's median patient age at 59, with 66% women.

In 2024, Dr. Stalling wrote 1,199 Medicare Part D claims for 440 patients. 93% of them were for generic drugs. CMS names the drug for 1,056 of them, across 24 drugs with 11 or more claims each, at $183,823 in total drug cost. In 2023, CMS named 895 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Stalling for performance year 2024, reported individually. Dr. Stalling accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 340 procedures of removal of skin lesions by Dr. Stalling, more than 83% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Stalling, published from 2008 to 2017. The most frequent topics are Cells, Cultured, Fibroblasts and Biocompatible Materials. Dr. Stalling's most frequent co-authors are Peter J. Taub, MD, Maria L. Wei, MD, PhD and Andrew Wei Ping Wong.

CMS Open Payments shows 341 general payments to Dr. Stalling from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $1,189.

Dr. Stalling graduated from Perelman School of Medicine - Philadelphia in 2010.

Dr. Stalling is in network with 23 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.